InvestorsHub Logo

Investor2014

01/23/22 12:51 PM

#346193 RE: bb8675309 #346192

Well it won't be until trials show A2-73 to prove what we hope and believe. So we will just have to wait.

rayovacAAA

01/23/22 1:37 PM

#346200 RE: bb8675309 #346192

THE VAST MAJORITY OF TRIAL PARTICIPANTS ADMINISTERED A2-73 HAVE BEEN UNDER THE JURISDICTION OF THE EMA & TGA, NOT THE FDA!!!!!!!!

A2-73 should already be approved with current drug trial data results and proven safety. Again, it should be up to the doctor and patients to decide if they want it. Tired of waiting for approval from the great and powerful wizard ( fda ) hiding behind a curtain while people in need are dying.



HOW HAS THE FDA PREVENTED THE EMA OR TGA FROM APPROVING A2-73???????





WE GOT THIS!!!!!!

BIOChecker4

01/23/22 3:34 PM

#346215 RE: bb8675309 #346192

A sponsor (in this case Anavex) has to file an New Drug Application (NDA) with the FDA before the agency will consider whether to approve a drug for use in the U.S. While I respect your concern for dying patients, your anger toward the FDA is misplaced. If not for the slow pace of clinical development and lack of focus at Anavex, I believe an NDA could have been filed long ago.